Masimo CEO open to settling with Apple over blood oxygen sensing patents

The Blood Oxygen sensor on the back crystal of Apple Watch
The Blood Oxygen sensor on the back crystal of Apple Watch

Masimo CEO Joe Kiani, head of the medical device maker that forced Apple to the brink of a ban on Apple Watch sales in the U.S., says Massimo is open to settling with the Cupertino Colossus.

Mark Gurman and Caroline Hyde for Bloomberg News:

The executive, speaking Tuesday on Bloomberg TV, said the “short answer is yes,” when asked if he’d settle, but he declined to say how much money he’d seek from Apple. Kiani said he would “work with them to improve their product.”

“They haven’t called,” he said. “It takes two to tango.”

The International Trade Commission ruled earlier this year that the Apple Watch violates two Masimo patents related to blood-oxygen sensing. The ITC imposed an import ban on the Ultra 2 and Series 9 models that goes into effect Dec. 25.

The restriction only applies to Apple’s own retail channels. Best Buy Co., Target Corp. and other resellers can continue to offer the products. But it’s put Apple in the unusual situation of having to pull a big moneymaker off its shelves during the all-important holiday season…

The medical industry veteran said he last spoke to Apple in 2013, when the iPhone maker discussed acquiring his company or hiring him to help with its in-house technology efforts. Any settlement talks would need to include an “honest dialogue” and an apology, he said.

An Apple spokesperson said that the ruling from the ITC is erroneous and should be reversed. The company plans to appeal the decision.


MacDailyNews Take: As we wrote earlier today, “If the ITC ruling is not vetoed, and a hardware change is required, expect Apple to pay up and settle this imbroglio with an offer that Masimo cannot refuse.”

Please help support MacDailyNews. Click or tap here to support our independent tech blog. Thank you!

Support MacDailyNews at no extra cost to you by using this link to shop at Amazon.

10 Comments

  1. Apple should just disable the useless cheap and basically never used crap pulse oximeter app. They dont need to change any hardware, just disable the feature in the phone and dont bother with it in the phone in the future. No one cares about this feature.

    Starve this parasite company pulling a heist about a feature no one cares about and no one buys the watch for.

    5
    28
  2. A small software update deleting the feature is all that’s required. Apple should just issue the update and turn it off and move on. No one cares about the useless pulse oximeter feature.

    2
    31
    1. As software can turn the relevant feature components both on and off, does the ITC ruling prevent any new patches/updates that modify those features? Will Apple have to release different update packages to infringing Apple Watches in the U.S. vs the rest of the world?

      1. There’s the fact none of these issues have been settled in an actual court yet. The ITC decision is a function of the executive branch, the actual court cases for patents are on going in California and Delaware. In the California case the jury favored 6 to 1 in favor of Apple, but a mistrial was called since it needs to be unanimous. This looming defeat in California is what spurned masismo to run and complain to the ITC admins.
        During the discovery phase of the California trial’s first run, masimo had access to confidential Apple Watch design documents, then created their own smart watch W1. Hence the lawsuit from Apple in Delaware for actual IP theft, hilariously the same vapid claim levied against Apple that they could never prove. Wonder why masimo was suddenly able to design a watch.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.